trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Abnormal expression of specific microRNAs is implicated in the pathogenesis of various human cancers.

the verdict
SUPPORTED
the evidence backs this
Recorded sources
6 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that abnormal expression of specific microRNAs is implicated in the pathogenesis of various human cancers?

Yes. Extensive scientific literature demonstrates that the abnormal expression of specific microRNAs is directly implicated in the pathogenesis, progression, and therapeutic resistance of numerous human cancers.

Verdict: SUPPORTED · 6 sources for, 0 against · Last checked

The analysis

The retrieved papers consistently support the claim that microRNA dysregulation plays a critical role in various human cancers, acting as either oncogenes or tumor suppressors across multiple malignancies. The evidence strongly favors the claim without refutation.

Evidence for · 6
2026
Reviews how miR-107 acts as either a tumor suppressor or oncomiR depending on context, demonstrating that microRNA dysregulation drives oncogenic phenotypes.
Get citation
MA, R., N, F., YM, A., EA, A., & SA, F. (2026). The paradox of miR-107 in oncology: dual roles as a tumor suppressor and oncomiR.. doi.org. https://doi.org/10.1038/s41417-026-01042-7

See more details
More for · 5
2026
Details how aberrant expression of microRNA-155 contributes to tumorigenesis by modulating tumor suppressor genes in various cancers.
Get citation
PSS, A., MP, A., & KMH, P. (2026). microRNA-155: a versatile noncoding RNA.. doi.org. https://doi.org/10.1007/s11033-026-11706-0

2026
Highlights how deregulated microRNA expression in cervical cancer interferes with key molecular pathways to drive tumor aggressiveness.
Get citation
GM, P., S, C., PRD, S., AJA, F., SMJ, B., RM, R., MMC, M., & RL, C. (2026). MicroRNA Dysregulation in HPV-Driven Cervical Cancer: A Review of Oncoprotein-Targeted Signaling Pathways.. doi.org. https://doi.org/10.3390/life16081332

2026
Links microRNA dysregulation in breast cancer to tumor initiation, progression, and metastasis.
Get citation
A, N., S, G., J, S., M, B., O, N., J, J., & Z, D. (2026). Bioinformatics Analysis of microRNAs Associated with Metastatic Potential in Breast Cancer.. doi.org. https://doi.org/10.3390/biology15080617

2026
Notes that specific miRNAs act as oncogenes or tumor suppressors in diffuse large B-cell lymphoma, influencing tumor survival and progression.
Get citation
C, J., L, J., O, M., M, O., B, F., & M, Z. (2026). Emerging Roles of MicroRNAs in Diffuse Large B-Cell Lymphoma: From Molecular Mechanisms to Clinical Translation, Liquid Biopsy, and Precision Medicine.. doi.org. https://doi.org/10.3390/biomedicines14091904

2026
Explains how microRNAs can be overexpressed as oncogenes or underexpressed as tumor suppressors to control aspects of cancer.
Get citation
C, B., A, R., J, K., & JJ, L. (2026). The Promise and Pursuit of MicroRNAs for Cancer Treatment.. doi.org. https://doi.org/10.3390/biom16081086

What does the evidence say?

The retrieved papers consistently support the claim that microRNA dysregulation plays a critical role in various human cancers, acting as either oncogenes or tumor suppressors across multiple malignancies. The evidence strongly favors the claim without refutation.

Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work